15 g tube.
DANLOX 10: packages containing 28 capsules. DANLOX 20: packages containing 14 and 28 capsules. DANLOX 40: packages containing 14 and 28 capsules.
packages containing 15 and 30 coated tablets.
Coated tablets: packages containing 14 coated tablets.
Extemporaneous Suspension: containers with powder to prepare 70 and 140 mL.
immunotherapy.Prevention of respiratory airways recurrent infections and acute infectious exacerbations of chronic bronchitis.
Adjunctive treatment of respiratory airway acute infection.
Dosage and Administration
Preventive treatment and/ or consolidation therapeutics: a daily capsule administered under fasting conditions during 10 consecutive days in a month during a total period of 3 months.
Treatment of acute episodes: a daily capsule administered under fasting conditions until the symptoms disappear (at least 10 days). When the treatment requires antibiotics simultaneous administration, the combination with BRONCHO-VAXOM is recommended from the beginning of the therapeutics.
Children from 6 months to 12 years old: The same use as for adults since BRONCHO-VAXOM “children” represents half dose of BRONCHO-VAXOM “adults”.
Note: BRONCHO-VAXOM “children” capsules may be opened and its content may be poured in a drink (fruit juice, milk, etc.) in cases in which the child has difficulties in swallowing.
known hypersensitivity to BRONCHO-VAXOM components.
Adults: packages containing 10 and 30 capsules. Children: packages containing 10 and 30 capsules.